Global Prostacyclin Market Survey and Trend Research 2018

September 2018 | 70 pages | ID: GB283134F32EN
99Strategy

Abstracts

Summary

Prostacyclin (also called prostaglandin I2 or PGI2) is a prostaglandin member of the eicosanoid family of lipid molecules. It inhibits platelet activation and is also an effective vasodilator. 
This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (United Therapeutics, Actelion (J & J), GSK, Teva, Tide Pharma, Tide Pharma, Bayer AG etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Prostacyclin Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 PROSTACYCLIN MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 United Therapeutics (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Actelion (J & J) (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 GSK (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Teva (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Tide Pharma (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Tide Pharma (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Bayer AG (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Prostacyclin Market 2012-2017, by Type, in USD Million
Table Global Prostacyclin Market Forecast 2018-2023, by Type, in USD Million
Table United Therapeutics Overview List
Table Prostacyclin Business Operation of United Therapeutics (Sales Revenue, Cost, Gross Margin)
Table Actelion (J & J) Overview List
Table Prostacyclin Business Operation of Actelion (J & J) (Sales Revenue, Cost, Gross Margin)
Table GSK Overview List
Table Prostacyclin Business Operation of GSK (Sales Revenue, Cost, Gross Margin)
Table Teva Overview List
Table Prostacyclin Business Operation of Teva (Sales Revenue, Cost, Gross Margin)
Table Tide Pharma Overview List
Table Prostacyclin Business Operation of Tide Pharma (Sales Revenue, Cost, Gross Margin)
Table Tide Pharma Overview List
Table Prostacyclin Business Operation of Tide Pharma (Sales Revenue, Cost, Gross Margin)
Table Bayer AG Overview List
Table Prostacyclin Business Operation of Bayer AG (Sales Revenue, Cost, Gross Margin)
Table Global Prostacyclin Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Prostacyclin Sales Revenue Share, by Companies, in USD Million
Table Prostacyclin Demand 2012-2017, by Application, in USD Million
Table Prostacyclin Demand Forecast 2018-2023, by Application, in USD Million
Table Global Prostacyclin Market 2012-2017, by Region, in USD Million
Table Prostacyclin Market Forecast 2018-2023, by Region, in USD Million

List Of Figures

LIST OF FIGURES

Figure Prostacyclin Industry Chain Structure
Figure Global Prostacyclin Market Growth 2012-2017, by Type, in USD Million
Figure Global Prostacyclin Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region